Prostate News and Research

RSS

UT Southwestern researchers develop new class of drugs for prostate cancer

A new study on prostate cancer describes a novel class of drugs developed by UT Southwestern Medical Center researchers that interrupts critical signaling needed for prostate cancer cells to grow.

29 May 2013

African Americans with prostate cancer experience longer treatment delays after diagnosis

Among men with prostate cancer, African Americans experience longer treatment delays after being diagnosed than Caucasians. That is the finding of an analysis published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

28 May 2013

Survey reveals low level of shared decision making between patients and physicians

A national survey sample of adults who had discussions with their physicians in the preceding two years about common medical tests, medications and procedures often did not reflect a high level of shared decision making, according to an article published online by JAMA Internal Medicine.

28 May 2013

St James's Institute of Oncology orders two Versa HD systems to improve patient care

St James's Institute of Oncology, a leading radiotherapy center in the UK, recently ordered two Versa HD™ systems, an advanced linear accelerator designed to improve patient care and treat a wide range of tumors throughout the body.

From Elekta 28 May 2013

Astellas submits application for marketing approval of enzalutamide for prostate cancer

Astellas Pharma Inc. and Medivation, Inc. today announced that Astellas has submitted an application for marketing approval of enzalutamide (generic name) to the Ministry of Health, Labour and Welfare in Japan for the treatment of prostate cancer.

24 May 2013

Potential new treatment approaches for liver diseases

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.

24 May 2013

Researchers use data to identify different forms of prostate cancers and effective treatment options

Some prostate cancer patients unnecessarily undergo surgery or harsh treatments because science fails to identify the differences between slow-growing and aggressive forms of the disease. Researchers at Case Western Reserve University and Johns Hopkins Medical Institutes are developing technology that allows patients to safely choose to do nothing, opt for relatively mild treatments or take drastic measures.

24 May 2013

Some aggressive forms of prostate cancer have similar genetic origins

Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings appear online today in the journal Cancer Research.

24 May 2013

Researchers explore targeted therapies for prostate cancer

Are certain drugs more effective against some types of prostate cancers than others? Researchers know that not all therapies work for all patients – the next question is to figure out how to match the right treatments with the right patients.

24 May 2013

SonaCare Medical highlights need for image-guided technologies to better identify prostate cancer

The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association, in San Diego.

24 May 2013

National Council urges consumers to select sunscreen products that offer broad spectrum protection

As millions of Americans prepare to enjoy the great outdoors this Memorial Day weekend, the National Council on Skin Cancer Prevention has designated the Friday before Memorial Day, May 24, 2013, as "Don't Fry Day" to raise awareness of the importance of practicing sun-safe behaviors.

23 May 2013

UC Irvine chemists create new method to identify clinically usable markers for prostate cancer in urine

Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published today in the Journal of the American Chemical Society.

23 May 2013

Mid-stream urine collection system: an interview with Giovanna Forte, Managing Director, Forte Medical

The mid-stream (MSU) is urine from the bladder, which carries the information clinicians need to accurately identify and diagnose a UTI, or in the case of antenatal patients, make sure all is well.

22 May 2013

Obesity directly tied to several cancers

"Obesity is a major risk factor for developing cancer, roughly the equivalent of tobacco use, and both are potentially reversible. Further, obese cancer patients do worse in surgery, with radiation or on chemotherapy - worse by any measure." Karen Basen-Engquist, Ph.D., Director of MD Anderson's new Center for Energy Balance in Cancer Prevention and Survivorship and professor of Behavioral Science.

22 May 2013

Research suggests that IMRT may not be more effective in patients who had prostatectomy

Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.

22 May 2013

Findings suggest that a prosaposin-based drug could block metastasis spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse models of prostate, breast and lung cancer.

22 May 2013

No significant benefit differences between IMRT and CRT therapies after prostatectomy

Use of the newer, more expensive intensity-modulated radiotherapy (IMRT) and use of the older conformal radiotherapy (CRT) after surgical removal of all or part of the prostate gland were associated with similar morbidity and cancer control outcomes, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.

21 May 2013

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA Department of Urology.

21 May 2013

Honokiol protects muscles from normal inflammation caused by intense exercise

Honokiol is a powerful polyphenol compound extracted from Magnolia officinalis bark. Extensive pre-clinical research shows that honokiol (pronounced ha-no-kee-ohl) supports cellular health and provides gentle relaxation, as well as being a potent antioxidant.

20 May 2013

People diagnosed with cancer are more likely to declare bankruptcy

People diagnosed with cancer are more than two-and-a-half times more likely to declare bankruptcy than those without cancer, according to a new study from Fred Hutchinson Cancer Research Center. Researchers also found that younger cancer patients had two- to five-fold higher bankruptcy rates compared to older patients, and that overall bankruptcy filings increased as time passed following diagnosis.

17 May 2013

Prostate News and Research

UT Southwestern researchers develop new class of drugs for prostate cancer

African Americans with prostate cancer experience longer treatment delays after diagnosis

Survey reveals low level of shared decision making between patients and physicians

St James's Institute of Oncology orders two Versa HD systems to improve patient care

Astellas submits application for marketing approval of enzalutamide for prostate cancer

Potential new treatment approaches for liver diseases

Researchers use data to identify different forms of prostate cancers and effective treatment options

Some aggressive forms of prostate cancer have similar genetic origins

Researchers explore targeted therapies for prostate cancer

SonaCare Medical highlights need for image-guided technologies to better identify prostate cancer

National Council urges consumers to select sunscreen products that offer broad spectrum protection

UC Irvine chemists create new method to identify clinically usable markers for prostate cancer in urine

Mid-stream urine collection system: an interview with Giovanna Forte, Managing Director, Forte Medical

Obesity directly tied to several cancers

Research suggests that IMRT may not be more effective in patients who had prostatectomy

Findings suggest that a prosaposin-based drug could block metastasis spread

No significant benefit differences between IMRT and CRT therapies after prostatectomy

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Honokiol protects muscles from normal inflammation caused by intense exercise

People diagnosed with cancer are more likely to declare bankruptcy

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News